Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2025-12-24 @ 12:19 PM
NCT ID:
NCT01901861
Eligibility Criteria:
Inclusion Criteria:
* Caucasian men with type 2 diabetes diagnosed according to ICD10
* Ongoing treatment with life style adjustment or life style adjustment together with metformin as oral antidiabetic. Metformin therapy should not exceed 2 grams daily
* Age 20-75 years
* HbA1c ≤80 mmol/mol
* BMI: 20-40 kg/m2
Exclusion Criteria:
* Liver disease or ALAT three times above upper reference range
* Diabetic nephropathy (GFR \< 50 mL/min/1.73 m2 or albuminuria)
* Proliferative diabetic retinopathy
* Treatment with any glucose-lowering medication except metformin
* Previous myocardial infarction, coronary heart disease or insatiable angina pectoris in the last 6 months.
* Previous surgery on the gastrointestinal tract
* Larger surgical intervention during the last 12 weeks
* Treatment with oral steroids or thiazide diuretics
* Treatment with digoxin
* Smokers
* Participation in another study the last 4 weeks
* Paracetamol intolerance
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT01901861
Study Brief:
Protocol Section:
NCT01901861